Arcutis Biotherapeutics, Inc. 4

EVP & Chief Medical Officer Patrick Burnett sold 222 shares of Arcutis Biotherapeutics, Inc. common stock at $21.05 per share to cover RSU tax withholding, leaving him with 120,244 shares owned.

On May 11, 2026, EVP and Chief Medical Officer Patrick Burnett of Arcutis Biotherapeutics, Inc. executed a small sale of 222 shares of common stock at an average price of $21.05 per share, for total proceeds of approximately $4,656, solely to cover tax withholding obligations associated with the vesting of restricted stock units. Following this routine tax-related transaction, Burnett beneficially owned 120,244 shares of Arcutis common stock directly.

Filing Facts

CIK

1787306

Ticker

ARQT

Form

4

Source Type

sec

Accession

0001741987-26-000004

Alert Tier

4